Pediatric cytochrome P450 activity alterations in nonalcoholic steatohepatitis

Medicine and Dentistry

• Pediatrics 100%
• Nonalcoholic Fatty Liver 100%
• Cytochrome P450 100%
• Adolescent 33%
• Metabolite 33%
• Enzyme Activity 33%
• Omeprazole 33%
• Drug Metabolism 33%
• Drug Response 33%
• CYP1A2 33%
• CYP2C19 33%
• CYP2C9 33%
• Ex Vivo 16%
• Pharmacodynamics 16%
• Liquid Chromatography 16%
• Tandem Mass Spectrometry 16%
• Disease Severity 16%
• Fatty Liver 16%
• Chronic Liver Disease 16%
• Pharmacokinetics 16%
• Venous Blood 16%
• Urinalysis 16%
• Midazolam 16%
• Losartan 16%
• CYP3A4 16%
• Drug Metabolizing Enzyme 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Cytochrome P450 100%
• Nonalcoholic Fatty Liver 100%
• Omeprazole 33%
• Drug Metabolism 33%
• CYP2C19 33%
• CYP1A2 33%
• CYP2C9 33%
• Pharmacokinetics 16%
• Pharmacodynamics 16%
• Disease Severity 16%
• Chronic Liver Disease 16%
• CYP3A4 16%
• Fatty Liver 16%
• Midazolam 16%
• Drug Metabolizing Enzyme 16%
• Losartan 16%

Keyphrases

• Parent Area 20%